Case Type: Mergers & Acquisitions

We are investigating MedEquities Realty Trust, Inc. (NYSE: MRT) regarding its sale to Omega Healthcare Investors, Inc. (OHI) for $2.00 in cash and 0.235 shares of Omega for each share of MedEquities.

We are investigating Loxo Oncology, Inc. (NasdaqGM: LOXO) regarding its sale to Eli Lilly Company for $235 per share.

We are investigating HopFed Bancorp, Inc. (NASDAQ GM: HFBC) regarding its sale to First Financial Corporation for $21.00 in cash or 0.444 shares of First Financial for each share of HopFed.

We are investigating Celgene Corporation (NasdaqGS: CELG) regarding its sale to Bristol-Myers Squibb Company for $50.00 in cash and 1.0 shares of Bristol-Myers for each share of Celgene.

We are investigating MINDBODY, Inc. (NasdaqGM: MB) regarding its sale to Vista Equity Partners for $36.50 in cash per share.

We are investigating Alliance MMA (NasdaqCM: AMMA) regarding its acquisition of SCWorx Corp. for the quotient of $50,000,000 divided by the closing price of Alliance MMA’s common stock at closing (subject to a price cap of $.67 per share).

We are investigating Haymaker Acquisition Corp. (NasdaqCM: HYAC) regarding its business combination with OneSpaWorld where each Haymaker common share will be converted into the right to receive one OneSpaWorld Share.

We are investigating Arsanis, Inc. (NasdaqGM: ASNS) regarding its acquisition of X4 Pharmaceuticals, Inc. (“X4”) for 0.5948 shares of Arsanis common stock for each share of X4.

We are investigating Medley Capital Corporation (NYSE: MCC) regarding its sale to Sierra Income Corporation (“Sierra”) for 0.8050 shares of Sierra for each share of Medley common stock.

We are investigating Western Gas Partners, LP (NYSE: WES) regarding its sale to Western Gas Equity Partners, LP for 1.525 WGP common units for each WES common unit.